Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. | Director | Common Stock | 2.07K | $15.1K | $7.29 | Jun 20, 2024 | Direct |
KINETA, INC./DE | Director | Stock Option (Right to Buy) | 12.5K | Sep 4, 2024 | Direct | ||
Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4.19K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KA | KINETA, INC./DE | Sep 4, 2024 | 1 | $0 | 4 | Sep 5, 2024 | Director |
APRE | Aprea Therapeutics, Inc. | Jun 20, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
APRE | Aprea Therapeutics, Inc. | Aug 23, 2023 | 2 | $0 | 4 | Aug 24, 2023 | Director |
KA | KINETA, INC./DE | Apr 12, 2023 | 2 | $0 | 4 | Apr 14, 2023 | Director |
KA | KINETA, INC./DE | Dec 16, 2022 | 1 | -$3.59K | 4 | Dec 20, 2022 | Director |
KA | YUMANITY THERAPEUTICS, INC. | Dec 2, 2022 | 1 | -$18.4K | 4 | Dec 6, 2022 | President and CEO, Director |
APRE | Aprea Therapeutics, Inc. | Jul 28, 2022 | 2 | $0 | 4 | Aug 1, 2022 | Director |
KA | YUMANITY THERAPEUTICS, INC. | Jul 5, 2022 | 1 | -$8.48K | 4 | Jul 6, 2022 | President and CEO, Director |
KA | YUMANITY THERAPEUTICS, INC. | Jun 3, 2022 | 1 | -$12.2K | 4 | Jun 6, 2022 | President and CEO, Director |
KA | YUMANITY THERAPEUTICS, INC. | Mar 28, 2022 | 1 | -$19.8K | 4 | Mar 30, 2022 | President and CEO, Director |
KA | YUMANITY THERAPEUTICS, INC. | Dec 1, 2021 | 1 | $0 | 4 | Dec 3, 2021 | President and CEO, Director |
KA | YUMANITY THERAPEUTICS, INC. | Jul 2, 2021 | 2 | -$50.2K | 4 | Jul 7, 2021 | President and CEO, Director |
APRE | Aprea Therapeutics, Inc. | Jun 30, 2021 | 2 | $0 | 4 | Jul 1, 2021 | Director |